Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

TREVICTA 350mg prolonged release suspension for injection

Active Ingredient:
paliperidone palmitate
Company:  
Janssen-Cilag Ltd (a Johnson & Johnson Company) See contact details
ATC code: 
N05AX13
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Product Information HCP Med Info
{arrow_left}
{arrow_right}
Information for Healthcare Professionals and Patients based in Northern Ireland

The Information present in the SmPC and Patient Leaflet is approved for Great Britain only.

To access the SmPC and Patient Leaflet approved for Northern Ireland, please use the following link: Trevicta 350 mg prolonged-release suspension for injection (Northern Ireland)
Janssen-Cilag Ltd (a Johnson & Johnson Company)
Company image
Address
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone
+44 (0)1494 567 567
Medical Information Fax
+44 (0) 1494 567 445
WWW
https://www.janssen.com/uk/
Fax
+44 (0)1494 567 568
Medical Information Direct Line
+44 (0)800 731 8450
Customer Care direct line
+44 (0)800 731 5550
Medical Information e-mail
[email protected]